In contrast to EC and GC, PD-L1 expression did not seem to be a suitable biomarker for HCC and CRC patients as several trials revealed that ICI responses were observed regardless of PD-L1 expression in these patients [61, 78, 80]. This evidence concerns the gene CD274 and colorectal carcinoma.